PFAS regulation is usually presented as a story about chemistry: how persistent “forever chemicals” move through water, how scientists establish safe levels, and how regulators force utilities and manufacturers to reduce them. But the deeper environmental-justice story is about something less visible: who gets measured, who gets warned, who can afford protection, and who has to wait for the science and regulation to catch up.

The U.S. Environmental Protection Agency’s 2023-2026 research planning makes that connection unusually clear. Its Chemical Safety for Sustainability (CSS) research program did not treat environmental justice as a separate research silo. Instead, EPA said that environmental justice, vulnerable populations, cumulative impacts and PFAS were to be integrated into the broader chemical-safety research program. The agency’s research agenda therefore points toward a more consequential idea: PFAS exposure is not simply a question of whether contamination exists. It is also a question of whether communities have the scientific information, regulatory visibility and financial capacity required to respond to it.

PFAS research was designed around an information problem

EPA’s Chemical Safety for Sustainability Strategic Research Action Plan for fiscal years 2023-2026, prepared by EPA’s Office of Research and Development, identifies a fundamental difficulty with PFAS: there are many chemicals, but comparatively incomplete information about their hazards and exposures.

The plan describes PFAS as structurally diverse chemicals that “typically lack adequate exposure and hazard information needed to support decisions.” That is more than a technical limitation. It creates a regulatory problem because a chemical cannot be effectively managed if regulators do not know where it is, how much is present, how people are exposed, or which populations face the greatest risk.

EPA therefore proposed research into PFAS exposure measurement, emissions, environmental fate, biomonitoring, toxicokinetics and methods for evaluating mixtures. The CSS plan specifically identified vulnerable and sensitive populations, children's environmental health and environmental justice as research needs associated with exposure assessment.

That structure is important. It means environmental justice is not merely a question that arises after a chemical has been regulated. It can influence the scientific questions that determine what regulators know in the first place.

The strongest evidence of unequal PFAS exposure comes from environmental geography

The environmental-justice dimension becomes much more concrete when EPA’s research agenda is considered alongside the findings of its National Environmental Justice Advisory Council (NEJAC).

In its November 2022 PFAS Work Group recommendations, the NEJAC reported that low-income communities, Indigenous communities and communities of color are disproportionately exposed to contamination associated with groundwater and drinking water sources, wastewater treatment plants, industrial facilities, military installations and airports. The advisory group cited an analysis showing that nearly 40,000 more low-income households and approximately 300,000 more people of color lived within five miles of PFAS-contaminated sites than would have been expected from U.S. Census patterns.

The figure needs to be interpreted carefully. Living within five miles of a contaminated site is not the same as proving that every person in that area has a higher biological dose of PFAS. Geography is a proxy for potential exposure, not a biomarker. Nevertheless, the disparity is significant because the locations identified as potential sources industrial sites, military facilities, airports and wastewater infrastructure are also pathways through which PFAS can enter water, soil, air and waste streams.

The Michigan comparison cited by NEJAC was even more pronounced. In the state with what the advisory group described as the most thorough PFAS testing at the time, the analysis found an excess of 36,170 low-income households and 134,488 people of color living within five miles of PFAS-contaminated sites compared with expectations based on Census data.

This produces a more useful environmental-justice question than simply asking whether PFAS contamination is widespread. The question becomes: where is monitoring strongest, where is it weakest, and do those differences systematically affect the communities that have the fewest resources to investigate contamination themselves?

The research agenda reveals why measurement is itself a justice issue

PFAS creates a peculiar regulatory challenge because there is no single “PFAS exposure.” There are thousands of chemicals in the broader PFAS universe, and they differ in structure, persistence, toxicity, environmental behavior and available evidence.

EPA’s 2023-2026 CSS plan therefore called for faster approaches to exposure evaluation. One research output specifically targeted methods, data and frameworks for rapid PFAS exposure assessment. Another called for new approaches to evaluate PFAS bioactivity and toxicity. The strategy also emphasized computational models, alternative testing methods and approaches capable of handling mixtures.

That matters for environmental justice because conventional regulatory science can unintentionally favor communities that already have better information. A wealthy municipality with a sophisticated water department may be able to commission additional testing, interpret laboratory results and install treatment before a federal compliance deadline. A small water system with limited technical staff may depend almost entirely on state and federal monitoring, grants and regulatory guidance.

The result is an information asymmetry. Two communities can face the same chemical hazard while having radically different abilities to discover it and respond.

EPA's research plan recognized the need to make scientific outputs usable for decision-making. Its stated vision included developing “frameworks that make the information and tools transparent and useful for decision making.” That phrase is especially important for PFAS. A scientific result that remains buried in a technical report is not equivalent, from a community perspective, to information that can be understood, located and acted upon.

Transparency is becoming part of PFAS regulation itself

The regulatory evolution of PFAS shows why transparency cannot be separated from environmental protection.

In April 2024, EPA finalized the first federal drinking-water standards for PFAS. The rule established enforceable maximum contaminant levels of 4.0 parts per trillion for PFOA and 4.0 parts per trillion for PFOS, while establishing different limits for PFHxS, PFNA and GenX chemicals and a hazard-index approach for certain mixtures.

The original rule required public water systems to complete initial monitoring and ultimately provide information to the public. EPA's framework therefore linked measurement directly to public disclosure: communities could not meaningfully understand their drinking-water risk without monitoring data.

But the regulatory picture has changed during 2026. On May 18, EPA proposed keeping the PFOA and PFOS limits while allowing qualifying water systems to request an extension of the compliance deadline from 2029 to 2031. Separately, EPA proposed rescinding the drinking-water regulations for PFHxS, PFNA, GenX chemicals and the associated hazard-index mixture, arguing that the previous regulatory process did not satisfy the requirements of the Safe Drinking Water Act.

As of September 13, 2026, these actions remain proposals rather than final changes. The public-comment period for both proposals closed on July 20, 2026. That distinction matters because a community reading headlines about a PFAS rollback could easily conclude that existing standards have already disappeared, while the regulatory situation is actually more complicated.

This is precisely where regulatory transparency becomes an environmental-health issue. The difference between a final rule, a proposed rule, an enforcement deadline and a future compliance extension is not merely legal terminology. It determines what a water utility must do, what residents can expect, and when they may receive information about contamination.

The 2026 debate makes the information gap even more important

The Trump administration’s EPA has framed the 2026 PFAS strategy around maintaining the PFOA and PFOS standards while making implementation more practical. The agency has also emphasized additional funding for PFAS treatment and a broader lifecycle approach.

At the same time, EPA has continued building information mechanisms around PFAS. In February 2026, the agency finalized the addition of sodium perfluorohexanesulfonate, or PFHxS-Na, to the Toxics Release Inventory. The reporting year began in 2026, with reports due in 2027. EPA said the change would strengthen communities’ ability to know what chemicals are being used and released around them.

That is a subtle but important shift in how PFAS policy can be understood. Regulation does not only operate through concentration limits. It also operates through information disclosure.

For communities located near industrial facilities, airports, military installations or waste-management infrastructure, a release inventory can provide the first clue that a potential source exists. Water monitoring can then establish whether contamination has entered a drinking-water supply. Biomonitoring and health studies can provide another layer of evidence. Each layer reduces uncertainty.

The reverse is also true. When reporting is delayed, monitoring is incomplete or data are difficult to interpret, uncertainty becomes concentrated in the communities least capable of resolving it independently.

Small and disadvantaged water systems face a different PFAS problem

The cost of PFAS compliance adds another environmental-justice dimension. Removing PFAS from drinking water is technically possible, but treatment systems require capital, engineering expertise, maintenance and monitoring.

Large metropolitan utilities can spread those costs across hundreds of thousands or millions of customers. Small systems cannot necessarily do so. A treatment requirement that appears technically reasonable at the national level may therefore have very different consequences depending on the size and financial condition of the affected water system.

EPA's 2026 PFAS strategy has recognized this problem through funding aimed at small and disadvantaged communities. In May 2026, for example, EPA announced more than $10.5 million for Tennessee through the Emerging Contaminants in Small or Disadvantaged Communities program. Similar funding announcements were made for other jurisdictions.

This is where environmental justice intersects with regulatory design. A standard without financing can shift costs toward the communities that have the least capacity to pay. A standard accompanied by targeted grants, technical assistance and transparent monitoring can instead reduce the disparity between communities.

The difference is not theoretical. For a small water system, the question may not be whether PFAS should be removed. It may be whether the system can afford the treatment, whether it can find qualified engineers, whether it can operate the technology reliably and whether its customers can absorb the resulting increase in water rates.

PFAS also exposes a weakness in the idea of a single safe number

Another insight from EPA's research agenda is that environmental justice cannot be reduced to comparing measured concentrations with a regulatory threshold.

The CSS research program emphasized cumulative impacts, mixtures, vulnerable populations and early-life susceptibility. That is significant because people are rarely exposed to one chemical at a time. A community near an industrial facility may experience PFAS exposure alongside other contaminants, socioeconomic stressors, poor housing conditions or other environmental burdens.

The scientific challenge is therefore not simply to determine whether PFOA in water is above or below 4 parts per trillion. It is to understand exposure across different routes and populations and to determine whether a regulatory measurement captures the real-world distribution of risk.

This is one reason EPA's interest in rapid exposure assessment, biomonitoring and computational approaches matters. Better science can reveal patterns that a single water-sample measurement cannot.

There is also an important temporal dimension. PFAS are persistent, and contamination can remain in environmental systems long after the original use or release has stopped. A community may therefore inherit exposure from historical industrial activity even when current emissions appear modest.

The real environmental-justice question may be who controls uncertainty

PFAS policy is often framed as a conflict between regulators, industry and environmental groups. But the more revealing conflict may be between communities that can reduce uncertainty themselves and communities that cannot.

Consider two hypothetical water systems with identical PFAS concentrations. One has an experienced laboratory and engineering department, a large tax base and access to outside consultants. The other has a small staff, aging infrastructure and limited financial reserves. The measured concentration may be identical, but the practical risk-management capacity is not.

This suggests a broader definition of environmental justice: equal protection may require something more than equal regulatory limits. It may require roughly equal access to measurement, interpretation, technical assistance, treatment funding and timely public information.

That perspective also changes how the success of PFAS regulation should be evaluated. A regulation should not be judged only by whether national average concentrations decline. Analysts should ask whether monitoring coverage improves in historically under-tested communities, whether disadvantaged systems receive resources quickly enough to act, whether residents can understand their results and whether the regulatory record makes clear how decisions were reached.

The next phase of PFAS policy will be a test of transparency

EPA's September 2026 research activity offers a useful reminder of where the science is heading. On September 9, the agency announced a new drinking-water study using broad analytical techniques to screen for PFAS, pharmaceuticals and more than 1,000 potential contaminants. EPA Administrator Lee Zeldin said, “We have heard loud and clear that Americans are concerned about potential unknown pollutants lurking in their drinking water.”

The statement captures the central challenge facing PFAS policy. The public is not concerned only about chemicals that regulators have already identified. It is also concerned about what remains unknown.

For environmental justice, that unknown space matters disproportionately. Communities with money, technical expertise and political influence can often commission studies, demand answers and attract regulatory attention. Communities without those resources are more dependent on public monitoring and transparent government data.

That makes EPA's 2023-2026 research agenda more consequential than it may initially appear. Its integration of PFAS, environmental justice, vulnerable populations, cumulative exposure and knowledge delivery points toward a regulatory model in which scientific transparency is itself a form of public-health protection.

The emerging lesson from PFAS is therefore not simply that some communities have more contamination than others. It is that the ability to know about contamination, prove its significance and obtain the resources necessary to respond is also unevenly distributed.

That may ultimately be the most important environmental-justice dimension of “forever chemicals.” The regulatory question is not only how low PFAS concentrations should be. It is also whether every community has a fair chance to discover its exposure, understand the evidence and act before uncertainty becomes another permanent burden.